Molecular docking of ursolic acid and Staphylococcus aureus ATPase for antibacterial therapy

Antibiotics have transformed the practice of medicine, making once lethal infections easily treatable and making other medical advances possible. The abuse of antibiotics has contributed to the growing problem of antibiotic resistance, which has become one of the most serious and growing threats to public health. Ursolic acid is one of the most promising substances of biological origin for antimicrobial therapy. A molecular docking with Staphylococcus aureus ATPase is presented.